Ready2Respond, a public-private collaborating platform to address pandemic preparedness gaps in low- and middle-income countries - Phase 2 Funding

Grant number: 224690/Z/21/Z

Grant search

Key facts

  • Disease

    COVID-19, Unspecified
  • Start & end year

    2021
    2022
  • Known Financial Commitments (USD)

    $504,317.89
  • Funder

    Wellcome Trust
  • Principal Investigator

    Dr. Marie Mazur
  • Research Location

    United States of America
  • Lead Research Institution

    Task Force for Global Health
  • Research Priority Alignment

    N/A
  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease surveillance & mapping

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Following a 2019 meeting of global health leaders with expertise in influenza, vaccinology and pandemic preparedness in London hosted at the Wellcome Trust, Ready2Respond was formed as a global collaboration of partners committed to enhancing low- and middle-income countries' readiness to respond against influenza and respiratory pandemics. With a Secretariat hosted at The Task Force for Global Health, Ready2Respond identified challenges and actionable solutions to promote pandemic preparedness. Though initially based on influenza, the organization's plan now includes COVID-19. Under the oversight of a Management Secretariat, Expert Working Groups design and execute cross- collaborative projects organized in 3 strategic pillars: - Burden of Disease - Risk Communication and Community Engagement - Vaccine Access Ready2Respond seeks a grant from the Wellcome Trust of US$ 492,970. This grant will enable Ready2Respond to focus on two initial and critical projects identified in the Burden of Disease pillar. This grant will also allow for retention of paid Director, responsible for ensuring that identified projects represent discrete operational improvement activities for LMICs, and cover part-time staff. Finally, this grant will help secure communication activities aimed at raising awareness and funding from potential partners. This Phase 2 of funding will span September 2021 - February 2022.

Publicationslinked via Europe PMC

Last Updated:38 minutes ago

View all publications at Europe PMC

Predictors of Severity of Influenza-Related Hospitalizations: Results From the Global Influenza Hospital Surveillance Network (GIHSN).

Correspondence to: Estimating the full health and economic benefits of current and future influenza vaccines.

Increased severity of influenza-associated hospitalizations in resource-limited settings: Results from the Global Influenza Hospital Surveillance Network (GIHSN)